Dermcidin may play role in the pathogenesis of skin disease hidradenitis suppurativa
(George Washington University) A team from the GW School of Medicine and Health Sciences have identified the protein dermcidin as having a potential role in the pathogenesis of the chronic skin disease hidradenitis suppurativa. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - April 25, 2019 Category: International Medicine & Public Health Source Type: news

Novel Agent Active in Dermatologic Conditions
(MedPage Today) -- High response rates with IL-1 alpha inhibitor in atopic dermatitis, hidradenitis suppurativa (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 4, 2019 Category: Dermatology Source Type: news

Several Minor Surgeries Preferred in Some Dermatology Cases Several Minor Surgeries Preferred in Some Dermatology Cases
Multiple step-by-step surgeries in place of a major procedure to remove diseased skin related to hidradenitis suppurativa can eliminate the need for skin grafts, a small pilot study shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 12, 2019 Category: Consumer Health News Tags: Dermatology News Source Type: news

Methotrexate Added to Biologic Eases Inflamed Skin Methotrexate Added to Biologic Eases Inflamed Skin
The combination of methotrexate and anti-TNF therapy can improve clinical response in patients with severe hidradenitis suppurativa, first results from a new study demonstrate.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 8, 2019 Category: Consumer Health News Tags: Dermatology News Source Type: news

Biomarkers to Pinpoint Hidradenitis Suppurativa Inch Forward Biomarkers to Pinpoint Hidradenitis Suppurativa Inch Forward
A lack of physician familiarity with the uncommon inflammatory skin condition points to a need for diagnostic biomarkers, experts say.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 7, 2019 Category: Consumer Health News Tags: Dermatology News Source Type: news

New Options Emerging for Painful Abscesses, Skin Scarring New Options Emerging for Painful Abscesses, Skin Scarring
Much-needed therapies for a chronic inflammatory skin condition, a once-orphan disease, will be in the spotlight at the upcoming Conference of the European Hidradenitis Suppurativa Foundation.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 22, 2019 Category: Consumer Health News Tags: Dermatology News Source Type: news

Amgen Releases AMGEVITA for Treatment of Inflammatory Diseases in Adults
The AMGEVITA is a biosimilar designed to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, psoriasis hidradenitis and panuveitis. The biosimilar is a citrate-free formula and will be released in twenty-eight  countries in the European Union.This story is related to the following:Biopharmaceuticals (Source: Industrial Newsroom - Health, Medical and Dental Supplies)
Source: Industrial Newsroom - Health, Medical and Dental Supplies - October 18, 2018 Category: Medical Devices Source Type: news

Early Win for Anti-IL-17 Drug in Hidradenitis Suppurativa
(MedPage Today) -- Responses in 14 of 18 patients with longstanding disease (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - September 18, 2018 Category: Primary Care Source Type: news

Hidradenitis suppurativa increases indirect  costs
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2018 Category: Drugs & Pharmacology Source Type: news

Hidradenitis Suppurativa
Title: Hidradenitis SuppurativaCategory: Diseases and ConditionsCreated: 8/14/2018 12:00:00 AMLast Editorial Review: 8/14/2018 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - August 14, 2018 Category: Dermatology Source Type: news

Women with hidradenitis suppurativa have an elevated risk of suicide - Tiri H, Huilaja L, Jokelainen J, Timonen M, Tasanen K.
[Abstract unavailable] Language: en... (Source: SafetyLit)
Source: SafetyLit - July 5, 2018 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news

Hidradenitis Suppurativa Tied to Increased Risk of Crohn's Disease Hidradenitis Suppurativa Tied to Increased Risk of Crohn's Disease
Patients with hidradenitis suppurativa (HS), a skin disorder characterized by painful nodules and abscesses, may be at increased risk for Crohn's disease (CD), and those with GI symptoms should be seen by a gastroenterologist, researchers in New York say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 1, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Are Hidradenitis and Rheumatoid Arthritis Related?
Title: Are Hidradenitis and Rheumatoid Arthritis Related?Category: Doctor's& Expert's views on SymptomsCreated: 10/17/2017 12:00:00 AMLast Editorial Review: 10/17/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - October 17, 2017 Category: Rheumatology Source Type: news

Increased suicide risk in patients with hidradenitis suppurativa - Thorlacis L, Cohen AD, Gislason GH, Jemec GBE, Egeberg A.
Patients with skin disorders are considered at a higher risk of depression and anxiety than the background population. Patients with hidradenitis suppurativa (HS) may be particularly affected. We explored the association between HS and depression, anxiety,... (Source: SafetyLit)
Source: SafetyLit - September 29, 2017 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Biofilm-based Treatment for Chronic Hidradenitis Suppurativa Biofilm-based Treatment for Chronic Hidradenitis Suppurativa
Mounting evidence that biofilms are involved in hidradenitis suppurativa suggests that a biofilm-based treatment strategy, such as used in other chronic wound infections, may be effective.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 15, 2017 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

New treatment options for common debilitating skin disease Hidradenitis suppurativa
(Trinity College Dublin) The research team behind the study pinpointed 'Th17' cells as mediating the disease (HS). A number of existing treatments target the same cellular pathway and may also be effective in treating HS. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 19, 2017 Category: Biology Source Type: news

Glaswegian woman with lumps in groin thought it was STI
Esme Munro, 35, from Glasgow, mistook the huge, puss-filled lumps for an STI until she was diagnosed  with hidradenitis suppurativa, caused by blocked sweat glands. (Source: the Mail online | Health)
Source: the Mail online | Health - June 13, 2017 Category: Consumer Health News Source Type: news

GRAPHIC IMAGES: Incurable skin condition causes painful abscesses - do you have symptoms?
HIDRADENITIS suppurativa is a painful, long-term skin condition that causes recurring boils and abscesses, usually around the armpits, groin, on the buttocks and under the breasts. (Source: Daily Express - Health)
Source: Daily Express - Health - June 9, 2017 Category: Consumer Health News Source Type: news

Hematological Parameters in Staging Hidradenitis Suppurativa Hematological Parameters in Staging Hidradenitis Suppurativa
What role could hematological markers potentially play in the evaluation of hidradenitis suppurativa?Wounds (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - June 5, 2017 Category: Pathology Tags: Dermatology Journal Article Source Type: news

Wound Healing and Hidradenitis Suppurativa
(MedPage Today) -- Draining lesions call for specialized attention (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - June 2, 2017 Category: Primary Care Source Type: news

Hidradenitis suppurativa, intimate partner violence, and sexual assault - Sisic M, Tan J, Lafreniere KD.
BACKGROUND: Sexual assault and intimate partner violence have never been examined in individuals with hidradenitis suppurativa. The research is important, because prior studies show higher incidences of intimate partner violence and sexual assault in indiv... (Source: SafetyLit)
Source: SafetyLit - May 12, 2017 Category: International Medicine & Public Health Tags: Jurisprudence, Laws, Legislation, Policies, Rules Source Type: news

European Commission Approves AMGEVITA ™ (Biosimilar Adalimumab) For The Treatment Of Certain Inflammatory Diseases
First Biosimilar Adalimumab Approved in the European Union THOUSAND OAKS, Calif., March 23, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the European Commission (EC) has granted marketing authorization for AMGEVITA™ (biosimilar adalimumab1) in all available indications. AMGEVITA is authorized for the treatment of certain inflammatory diseases in adults, including moderate-to-severe rheumatoid arthritis; psoriatic arthritis; severe active ankylosing spondylitis (AS); severe axial spondyloarthritis without radiographic evidence of AS; moderate-to-severe chronic plaque psoriasis; moderate-to-s...
Source: Amgen News Release - March 23, 2017 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

AbbVie's HUMIRA(R) (Adalimumab) Receives CHMP Positive Opinion to Treat Adolescents with Hidradenitis Suppurativa, a Chronic Inflammatory Skin Disease
NORTH CHICAGO, Ill., Nov. 14, 2016 -- (Healthcare Sales & Marketing Network) -- AbbVie (ABBV), a global biopharmaceutical company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has gr... Biopharmaceuticals, Dermatology, Regulatory AbbVie, HUMIRA, adalimumab, hidradenitis suppurativa (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 14, 2016 Category: Pharmaceuticals Source Type: news

Adalimumab for the Treatment of Hidradenitis Suppurativa Adalimumab for the Treatment of Hidradenitis Suppurativa
Hidradenitis suppurativa is a severe and chronic auto-inflammatory disease, with few therapeutic options, but recent Phase III clinical trials on the efficacy of adalimumab show promise.Skin Therapy Letter (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 26, 2016 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Humira Partially Effective Against Hidradenitis Suppurativa Humira Partially Effective Against Hidradenitis Suppurativa
The anti-inflammatory drug adalimumab can provide significant relief for about a quarter of people who suffer from a moderate-to-severe case of the chronic skin condition hidradenitis suppurativa, according to two 36-week trials.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 4, 2016 Category: Consumer Health News Tags: Dermatology News Source Type: news

Clinical trial results support adalimumab treatment for painful skin condition
The results of two phase 3 clinical trials that led to FDA approval of adalimumab for treatment of the chronic inflammatory skin disease hidradenitis suppurtiva are now being published. An inhibitor of the inflammatory protein tumor necrosis factor, adalimumab is the first such medication approved to treat the painful skin disorder. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 4, 2016 Category: Science Source Type: news

Studies highlight diagnostic and treatment challenges in hidradenitis suppurativa
SCOTTSDALE, ARIZ. – Patients with hidradenitis suppurativa (HS) may be misdiagnosed when they see providers who are not dermatologists – as is usually the case during the initial years of their disease, according to a large analysis of medical claims data. The findings highlight the need for... (Source: Skin and Allergy News)
Source: Skin and Allergy News - August 3, 2016 Category: Dermatology Source Type: news

Hidradenitis suppurativa and diet: What's recommended?
(Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - July 6, 2016 Category: Consumer Health News Source Type: news

Thousands are too embarrassed about boils to seek help 
Hidradenitis suppurativa, or HS, affects three times as many women as men. Lorraine McPhail, 34, from Cumbernauld, North Lanarkshire, suffers from it. (Source: the Mail online | Health)
Source: the Mail online | Health - May 10, 2016 Category: Consumer Health News Source Type: news

UK NICE recommends Humira as treatment for hidradenitis suppurativa
The National Institute for Health and Care Excellence (NICE) has recommended the use of biopharmaceutical company AbbVie's Humira (adalimumab) for treatment of hidradenitis suppurativa (HS) in adults. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - May 9, 2016 Category: Pharmaceuticals Source Type: news

Risk of IBD doubled in hidradenitis suppurativa
WASHINGTON – Patients with hidradenitis suppurativa (HS) face an increased risk of also developing inflammatory bowel disease (IBD), Ahuva Cices said at the annual meeting of the American Academy of... (Source: Family Practice News)
Source: Family Practice News - April 4, 2016 Category: Primary Care Source Type: news

Uncontrolled hidradenitis suppurativa costs the health care system
WASHINGTON – One in four hidradenitis suppurativa patients saw their disease become more severe, requiring significantly more health care resources and driving up health care spending. Dr. Alexa Boer Kimball, professor of dermatology at Harvard Medical School, Boston, and her colleagues reviewed... (Source: Skin and Allergy News)
Source: Skin and Allergy News - March 5, 2016 Category: Dermatology Source Type: news

Hidradenitis Suppurativa Tied to Higher MortalityHidradenitis Suppurativa Tied to Higher Mortality
Hidradenitis suppurativa (HS) is associated with a significantly increased risk of adverse cardiovascular (CV) outcomes and all-cause mortality, according to Danish researchers. Reuters Health Information (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - February 25, 2016 Category: Dermatology Tags: Family Medicine/Primary Care News Source Type: news

Hidradenitis Suppurativa Linked With CV Risks (CME/CE)
(MedPage Today) -- Risks increased for MI, stroke, and cardiovascular death (Source: MedPage Today State Required CME)
Source: MedPage Today State Required CME - February 17, 2016 Category: Consumer Health News Source Type: news

Hidradenitis suppurativa and risk of adverse cardiovascular events, death
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease marked by painful abscesses that develop in areas where there are large numbers of sweat glands. The disease has been associated with cardiovascular risk factors, such as smoking and obesity, but the risk of cardiovascular disease in patients with HS is unknown. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 17, 2016 Category: Science Source Type: news

Elevated cardiovascular risks linked to hidradenitis suppurativa
The inflammatory skin disease hidradenitis suppurativa is associated with significantly increased risks of adverse cardiovascular outcomes such as ischemic stroke, myocardial infarction, and... (Source: Clinical Neurology News)
Source: Clinical Neurology News - February 17, 2016 Category: Neurology Source Type: news

Elevated cardiovascular risks linked to hidradenitis suppurativa
The inflammatory skin disease hidradenitis suppurativa is associated with significantly increased risks of adverse cardiovascular outcomes such as ischemic stroke, myocardial infarction, and cardiovascular mortality, according to results of a population-based study. A population-based cohort study... (Source: Skin and Allergy News)
Source: Skin and Allergy News - February 17, 2016 Category: Dermatology Source Type: news

AbbVie's HUMIRA(R) (Adalimumab) Receives First and Only Health Canada Approval for Moderate to Severe Hidradenitis Suppurativa
Hidradenitis suppurativa (HS) is a painful chronic inflammatory skin disease MONTREAL, Jan. 6, 2016 (Healthcare Sales & Marketing Network) - AbbVie, a global biopharmaceutical company, today announced that Health Canada approved HUMIRA® (adalimumab)... Biopharmaceuticals, RegulatoryAbbVie, HUMIRA, adalimumab, hidradenitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 6, 2016 Category: Pharmaceuticals Source Type: news

Anakinra shows promise for hidradenitis suppurativa
The results of a pilot study suggest that the interleukin-1(IL-1) receptor antagonist anakinra may be a potential treatment option for hidradenitis suppurativa (HS). The cause of HS – a chronic skin disorder affecting areas with apocrine glands leading to nodules, inflammation, rupture, and... (Source: Skin and Allergy News)
Source: Skin and Allergy News - December 1, 2015 Category: Dermatology Source Type: news

Anakinra Shows Promise in Hidradenitis Suppurativa Anakinra Shows Promise in Hidradenitis Suppurativa
Anakinra reduced disease activity in two thirds of patients with hidradenitis suppurativa, although it is unclear how to determine which patients would be most likely to benefit. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 23, 2015 Category: Consumer Health News Tags: Dermatology News Source Type: news

EADV: Hidradenitis suppurativa carries high cardiovascular risk
COPENHAGEN – Hidradenitis suppurativa, a common, chronic, inflammatory scarring skin disease of the hair follicles, is a red flag signaling elevated levels of multiple cardiovascular risk factors, according to a systematic review and meta-analysis.
Source: Skin and Allergy News - October 26, 2015 Category: Dermatology Source Type: news

EADV: Comorbid spondyloarthropathy common in hidradenitis suppurativa
COPENHAGEN – Back pain is surprisingly common in patients with hidradenitis suppurativa, and more than half of affected patients showed MRI evidence of axial spondyloarthropathy, Dr. Sylke Schneider-Burrus reported at the Annual Congress of the European Academy of Dermatology and Venereology.... (Source: Skin and Allergy News)
Source: Skin and Allergy News - October 22, 2015 Category: Dermatology Source Type: news

New FDA approval for adalimumab: Hidradenitis suppurativa
The approval of adalimumab has been expanded to include the treatment of moderate to severe hidradenitis suppurativa. Approval is based on the results of two phase III studies, PIONEER Iand
Source: Skin and Allergy News - September 24, 2015 Category: Dermatology Source Type: news

FDA Clears Adalimumab (Humira) for Hidradenitis SuppurativaFDA Clears Adalimumab (Humira) for Hidradenitis Suppurativa
The TNF blocker becomes the first and only FDA-approved agent for treatment of moderate to severe hidradenitis suppurativa. Orphan Drug Approvals (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 11, 2015 Category: Dermatology Tags: Dermatology News Alert Source Type: news

AbbVie's HUMIRA(R) (Adalimumab) Receives First and Only U.S. Food and Drug Administration Approval for Moderate to Severe Hidradenitis Suppurativa
Hidradenitis suppurativa (HS) is a painful, chronic inflammatory skin disease FDA granted HUMIRA orphan drug designation for moderate to severe HS (Hurley Stage II and Hurley Stage III disease) in May NORTH CHICAGO, Ill., Sept. 10, 2015 -- (Healthcar... Biopharmaceuticals, Dermatology, FDAAbbVie, hidradenitis suppurativa, HUMIRA, adalimumab) (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 11, 2015 Category: Pharmaceuticals Source Type: news

AbbVie receives European approval for Humira to treat hidradenitis suppurativa
AbbVie has received approval from the European Commission (EC) for its Humira (adalimumab) to treat moderate-to-severe hidradenitis suppurativa (HS or acne inversa), which is a painful and chronic inflammatory skin disease. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - July 31, 2015 Category: Pharmaceuticals Source Type: news

Hidradenitis Suppurativa: Acne Inversa - Causes, Symptoms & Treatment
Hidradenitis suppurativa is a form of chronic skin condition featuring pea-sized to marble-sized lumps underneath a person's skin. The condition is also known as, 'acne inversa,' and deep-seated lumps commonly develop where a person's skin rubs together, such as in the groin area, armpits, underneath breasts or between buttocks. The lumps associated with hidradenitis suppurativa are often times painful and might break open and drain bad-smelling pus. (Source: Disabled World)
Source: Disabled World - July 8, 2015 Category: Disability Tags: Skin Conditions Source Type: news